(Q37466717)

English

A study of the safety and efficacy of calcipotriol and betamethasone dipropionate scalp formulation in the long-term management of scalp psoriasis

scientific article published on 12 September 2008

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

A study of the safety and efficacy of calcipotriol and betamethasone dipropionate scalp formulation in the long-term management of scalp psoriasis (English)

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

1 reference

based on heuristic

inferred from title

author name string

T A Luger

1

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

F Cambazard

2

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

F G Larsen

3

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

M Bourcier

4

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

G Gupta

5

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

F Clonier

6

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

P Kidson

7

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

N H Shear

8

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

publication date

12 September 2008

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

217

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

4

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

321-328

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Calcipotriol/betamethasone dipropionate for the treatment of psoriasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790732

23 August 2017

Consistency of data in six phase III clinical studies of a two-compound product containing calcipotriol and betamethasone dipropionate ointment for the treatment of psoriasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790732

23 August 2017

Psoriasis treatment: traditional therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790732

23 August 2017

Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790732

23 August 2017

Psoriasis of the scalp. Diagnosis and management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790732

23 August 2017

Dose-dependent effect of topical corticosteroids on blood flow in human cutaneous tissue

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790732

6 September 2017

Calcipotriol (MC 903), a novel vitamin D3 analogue stimulates terminal differentiation and inhibits proliferation of cultured human keratinocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790732

26 June 2018

A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790732

2 September 2018

A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790732

2 September 2018

Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790732

2 September 2018

A randomized, investigator-masked clinical evaluation of the efficacy and safety of clobetasol propionate 0.05% shampoo and tar blend 1% shampoo in the treatment of moderate to severe scalp psoriasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790732

2 September 2018

Objective assessment of compliance with psoriasis treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790732

2 September 2018

Patients' vehicle preference for corticosteroid treatments of scalp psoriasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790732

2 September 2018

Efficacy of betamethasone valerate mousse in comparison with standard therapies on scalp psoriasis: an open, multicentre, randomized, controlled, cross-over study on 241 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2790732

2 September 2018

Natural history and treatment of scalp psoriasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18787325

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Scalp psoriasis, clinical presentations and therapeutic management

1 reference

https://pubmed.ncbi.nlm.nih.gov/18787325

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Calcipotriol cream with or without concurrent topical corticosteroid in psoriasis: tolerability and efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18787325

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris

1 reference

https://pubmed.ncbi.nlm.nih.gov/18787325

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clobetasol propionate foam 0.05% as a novel topical formulation for plaque-type and scalp psoriasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18787325

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term treatment of psoriasis with calcipotriol scalp solution and cream

1 reference

https://pubmed.ncbi.nlm.nih.gov/18787325

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patient compliance and disease management in the treatment of psoriasis in the Netherlands

1 reference

https://pubmed.ncbi.nlm.nih.gov/18787325

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1159/000155642

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37466717&oldid=2102867376"